Nuclear export inhibition through covalent conjugation and hydrolysis of Leptomycin B by CRM1
Qingxiang Sun(University of Electronic Science and Technology of China), Yuh Min Chook(The University of Texas Southwestern Medical Center), Xiaofeng Guo(The University of Texas Southwestern Medical Center), John B. MacMillan(The University of Texas Southwestern Medical Center), Hamid Mirzaei(Southwestern Medical Center), Y. Carrasco(The University of Texas Southwestern Medical Center), Youcai Hu(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 196
Related Papers
Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains
|Cell|2018|487
Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia
|Blood|2012|300
Structural Basis for the Inhibition Mechanism of Human Cystathionine γ-Lyase, an Enzyme Responsible for the Production of H2S
|Journal of Biological Chemistry|2008|206
Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells
|Leukemia|2012|193
Nuclear transport proteins: structure, function and disease relevance
|Signal Transduction and Targeted Therapy|2023|178